InterVenn Investigator Initiated Research Program in Glycoproteomics

First of its kind

InterVenn is building unique, powerful liquid-biopsy solutions by leveraging the rich diversity of protein glycosylation.

Glycosylation is the process of attaching sugar molecules to a variety of biological materials such as proteins, lipids and even RNA. Glycosylation is essential for normal cell and organ functions, but alterations have been associated with a variety of diseases including cancer.

Artificial Intelligence

InterVenn is decoding the glycoproteome using powerful analytics, and AI-powered software.

InterVenn is the cutting-edge leader for glycoprotein analysis, biomarker research, liquid-biopsy assay development, and new drug target discovery. Our unique platform uses deep learning to automate analysis of a rich field of biomarkers so diverse and complex that it would be otherwise inaccessible.

Ready to use

InterVenn’s unique, powerful liquid biopsy platform is available today.

Our solutions are suitable for a variety of studies - untargeted (discovery) and targeted (quantification), other proof-of-concept initiatives and biomarker development. Together and with a single-blood draw, we can revolutionize disease insights into opportunities for patients. Today.

Get Started Today